These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 38066372)
1. A Review of Phage Therapy for Bone and Joint Infections. Ferry T Methods Mol Biol; 2024; 2734():207-235. PubMed ID: 38066372 [TBL] [Abstract][Full Text] [Related]
2. Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection. Ferry T; Kolenda C; Briot T; Souche A; Lustig S; Josse J; Batailler C; Pirot F; Medina M; Leboucher G; Laurent F; On Behalf Of The Lyon Bji Study Group ; On Behalf Of The PHAGEinLYON Study Group Viruses; 2021 Dec; 13(12):. PubMed ID: 34960683 [TBL] [Abstract][Full Text] [Related]
3. Phage Therapy as a Novel Therapeutic for the Treatment of Bone and Joint Infections. Suh GA; Ferry T; Abdel MP Clin Infect Dis; 2023 Nov; 77(Suppl 5):S407-S415. PubMed ID: 37932115 [TBL] [Abstract][Full Text] [Related]
4. [Phage therapy, an additional strategy against multidrug-resistant bacteria]. Boniver M; Wotquenne P; Moutschen M; Rousseau AF Rev Med Liege; 2022 Sep; 77(9):510-515. PubMed ID: 36082597 [TBL] [Abstract][Full Text] [Related]
5. Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope. Kulshrestha M; Tiwari M; Tiwari V Microb Pathog; 2024 Jan; 186():106467. PubMed ID: 38036110 [TBL] [Abstract][Full Text] [Related]
6. Isolation and Characterization of Three Pseudomonas aeruginosa Viruses with Therapeutic Potential. Wang X; Tang J; Dang W; Xie Z; Zhang F; Hao X; Sun S; Liu X; Luo Y; Li M; Gu Y; Wang Y; Chen Q; Shen X; Xu L Microbiol Spectr; 2023 Jun; 11(3):e0463622. PubMed ID: 37125933 [TBL] [Abstract][Full Text] [Related]
7. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy. Tagliaferri TL; Jansen M; Horz HP Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237 [TBL] [Abstract][Full Text] [Related]
8. Big Impact of the Tiny: Bacteriophage-Bacteria Interactions in Biofilms. Hansen MF; Svenningsen SL; Røder HL; Middelboe M; Burmølle M Trends Microbiol; 2019 Sep; 27(9):739-752. PubMed ID: 31128928 [TBL] [Abstract][Full Text] [Related]
14. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields. Jamal M; Bukhari SMAUS; Andleeb S; Ali M; Raza S; Nawaz MA; Hussain T; Rahman SU; Shah SSA J Basic Microbiol; 2019 Feb; 59(2):123-133. PubMed ID: 30485461 [TBL] [Abstract][Full Text] [Related]
16. Phage therapy for severe bacterial infections: a narrative review. Petrovic Fabijan A; Khalid A; Maddocks S; Ho J; Gilbey T; Sandaradura I; Lin RC; Ben Zakour N; Venturini C; Bowring B; Iredell JR Med J Aust; 2020 Apr; 212(6):279-285. PubMed ID: 31587298 [TBL] [Abstract][Full Text] [Related]
17. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts. Royer S; Morais AP; da Fonseca Batistão DW Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609 [TBL] [Abstract][Full Text] [Related]
18. Propagation, Purification, and Characterization of Bacteriophages for Phage Therapy. Kosznik-Kwaśnicka K; Topka G; Mantej J; Grabowski Ł; Necel A; Węgrzyn G; Węgrzyn A Methods Mol Biol; 2024; 2738():357-400. PubMed ID: 37966610 [TBL] [Abstract][Full Text] [Related]
19. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far. Łusiak-Szelachowska M; Międzybrodzki R; Drulis-Kawa Z; Cater K; Knežević P; Winogradow C; Amaro K; Jończyk-Matysiak E; Weber-Dąbrowska B; Rękas J; Górski A J Biomed Sci; 2022 Mar; 29(1):23. PubMed ID: 35354477 [TBL] [Abstract][Full Text] [Related]
20. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going? Luong T; Salabarria AC; Roach DR Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]